Clinical Trial Update: OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating omega-3 polyunsaturated fatty acids (N3-Pufa) in Peripheral Arterial Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Omega-3 Polyunsaturated Fatty Acids (N3-Pufa) (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Medical University of Vienna | Conditions: Peripheral Arterial Disease | Phase 3 | Status: COMPLETED